- Home
- SQNS vs CTOR Comparison
SQNS vs CTOR Comparison
Compare SQNS & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- CTOR
- Stock Information
- Founded
- SQNS 2003
- CTOR 2021
- Country
- SQNS France
- CTOR United States
- Employees
- SQNS N/A
- CTOR N/A
- Industry
- SQNS Semiconductors
- CTOR
- Sector
- SQNS Technology
- CTOR
- Exchange
- SQNS Nasdaq
- CTOR NYSE
- Market Cap
- SQNS 46.5M
- CTOR 63.7M
- IPO Year
- SQNS 2011
- CTOR N/A
- Fundamental
- Price
- SQNS $4.52
- CTOR $2.87
- Analyst Decision
- SQNS Strong Buy
- CTOR Buy
- Analyst Count
- SQNS 1
- CTOR 2
- Target Price
- SQNS $7.50
- CTOR $6.00
- AVG Volume (30 Days)
- SQNS 9.6M
- CTOR 2.7M
- Earning Date
- SQNS 08-22-2025
- CTOR 08-11-2025
- Dividend Yield
- SQNS N/A
- CTOR N/A
- EPS Growth
- SQNS N/A
- CTOR N/A
- EPS
- SQNS 2.16
- CTOR N/A
- Revenue
- SQNS $38,858,000.00
- CTOR N/A
- Revenue This Year
- SQNS N/A
- CTOR N/A
- Revenue Next Year
- SQNS $93.87
- CTOR N/A
- P/E Ratio
- SQNS $1.81
- CTOR N/A
- Revenue Growth
- SQNS 40.06
- CTOR N/A
- 52 Week Low
- SQNS $0.95
- CTOR $0.55
- 52 Week High
- SQNS $5.50
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- SQNS 87.95
- CTOR N/A
- Support Level
- SQNS $1.34
- CTOR N/A
- Resistance Level
- SQNS $2.68
- CTOR N/A
- Average True Range (ATR)
- SQNS 0.52
- CTOR 0.00
- MACD
- SQNS 0.29
- CTOR 0.00
- Stochastic Oscillator
- SQNS 76.77
- CTOR 0.00
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.